Holtmann, Martin Hermann

[["dc.bibliographiccitation.firstpage","214"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","Brain Sciences"],["dc.bibliographiccitation.volume","11"],["dc.contributor.affiliation","Kaiser, Anna; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, anna.kaiser@zi-mannheim.de"],["dc.contributor.affiliation","Aggensteiner, Pascal-M.; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Pascal.Aggensteiner@zi-mannheim.de"],["dc.contributor.affiliation","Holtmann, Martin; \t\t \r\n\t\t LWL-University Hospital for Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, Ruhr University Bochum, 59071 Hamm, Germany, martin.holtmann@lwl.org"],["dc.contributor.affiliation","Fallgatter, Andreas; \t\t \r\n\t\t Tübingen University Hospital for Psychiatry and Psychotherapy, 72076 Tübingen, Germany, Andreas.Fallgatter@med.uni-tuebingen.de"],["dc.contributor.affiliation","Romanos, Marcel; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, 97080 Würzburg, Germany, Romanos_M@ukw.de"],["dc.contributor.affiliation","Abenova, Karina; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Karina.Abenova@zi-mannheim.de"],["dc.contributor.affiliation","Alm, Barbara; \t\t \r\n\t\t Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Barbara.Alm@zi-mannheim.de"],["dc.contributor.affiliation","Becker, Katja; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Medical Faculty Philipps-University Marburg and University Hospital Marburg, 35039 Marburg, Germany, katja.becker@med.uni-marburg.de\t\t \r\n\t\t Center for Mind, Brain and Behavior (CMBB), University of Marburg and Justus Liebig University Giessen, 35032 Marburg, Germany, katja.becker@med.uni-marburg.de"],["dc.contributor.affiliation","Döpfner, Manfred; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany, manfred.doepfner@uk-koeln.de"],["dc.contributor.affiliation","Ethofer, Thomas; \t\t \r\n\t\t Tübingen University Hospital for Psychiatry and Psychotherapy, 72076 Tübingen, Germany, Thomas.Ethofer@med.uni-tuebingen.de"],["dc.contributor.affiliation","Freitag, Christine; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Frankfurt, Goethe University, 60323 Frankfurt am Main, Germany, C.Freitag@em.uni-frankfurt.de"],["dc.contributor.affiliation","Geissler, Julia; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, 97080 Würzburg, Germany, Geissler_J@ukw.de"],["dc.contributor.affiliation","Hebebrand, Johannes; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany, johannes.hebebrand@lvr.de"],["dc.contributor.affiliation","Huss, Michael; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany, m.huss@rfk.landeskrankenhaus.de"],["dc.contributor.affiliation","Jans, Thomas; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, 97080 Würzburg, Germany, Jans_T@ukw.de"],["dc.contributor.affiliation","Jendreizik, Lea; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany, lea.jendreizik@uk-koeln.de"],["dc.contributor.affiliation","Ketter, Johanna; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Medical Faculty Philipps-University Marburg and University Hospital Marburg, 35039 Marburg, Germany, ketterj@med.uni-marburg.de"],["dc.contributor.affiliation","Legenbauer, Tanja; \t\t \r\n\t\t LWL-University Hospital for Child and Adolescent Psychiatry, Psychotherapy, and Psychosomatics, Ruhr University Bochum, 59071 Hamm, Germany, tanja.legenbauer@lwl.org"],["dc.contributor.affiliation","Philipsen, Alexandra; \t\t \r\n\t\t Department of Psychiatry and Psychotherapy, University of Bonn, 53127 Bonn, Germany, Alexandra.Philipsen@ukbonn.de"],["dc.contributor.affiliation","Poustka, Luise; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, 37075 Göttingen, Germany, luise.poustka@med.uni-goettingen.de"],["dc.contributor.affiliation","Renner, Tobias; \t\t \r\n\t\t Department of Child and Adolescence Psychiatry and Psychotherapy, University of Tübingen, 72076 Tübingen, Germany, tobias.renner@med.uni-tuebingen.de"],["dc.contributor.affiliation","Retz, Wolfgang; \t\t \r\n\t\t Department of Psychiatry and Psychotherapy, University Medical Center Mainz, 55131 Mainz, Germany, wolfgang.retz@unimedizin-mainz.de\t\t \r\n\t\t Institute for Forensic Psychology and Psychiatry, Saarland University, 66424 Homburg, Germany, wolfgang.retz@unimedizin-mainz.de"],["dc.contributor.affiliation","Rösler, Michael; \t\t \r\n\t\t Institute for Forensic Psychology and Psychiatry, Saarland University, 66424 Homburg, Germany, Michael.Roesler@uks.eu"],["dc.contributor.affiliation","Thome, Johannes; \t\t \r\n\t\t Department of Psychiatry and Psychotherapy, University Medical Center Rostock, 18055 Rostock, Germany, johannes.thome@med.uni-rostock.de"],["dc.contributor.affiliation","Uebel-von Sandersleben, Henrik; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, 37075 Göttingen, Germany, huebel@gwdg.de"],["dc.contributor.affiliation","von Wirth, Elena; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, Faculty of Medicine and University Hospital Cologne, University of Cologne, 50931 Cologne, Germany, elena.von-wirth@uk-koeln.de"],["dc.contributor.affiliation","Zinnow, Toivo; \t\t \r\n\t\t Institute for Forensic Psychology and Psychiatry, Saarland University, 66424 Homburg, Germany, Toivo.Zinnow@uks.eu"],["dc.contributor.affiliation","Hohmann, Sarah; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Sarah.Hohmann@zi-mannheim.de"],["dc.contributor.affiliation","Millenet, Sabina; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Sabina.Millenet@zi-mannheim.de"],["dc.contributor.affiliation","Holz, Nathalie; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Nathalie.Holz@zi-mannheim.de"],["dc.contributor.affiliation","Banaschewski, Tobias; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, tobias.banaschewski@zi-mannheim.de"],["dc.contributor.affiliation","Brandeis, Daniel; \t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, 68159 Mannheim, Germany, Daniel.Brandeis@zi-mannheim.de\t\t \r\n\t\t Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zürich, 8032 Zürich, Switzerland, Daniel.Brandeis@zi-mannheim.de\t\t \r\n\t\t Center for Integrative Human Physiology, University of Zürich, 8057 Zürich, Switzerland, Daniel.Brandeis@zi-mannheim.de\t\t \r\n\t\t Neuroscience Center Zürich, Swiss Federal Institute of Technology and University of Zürich, 8057 Zürich, Switzerland, Daniel.Brandeis@zi-mannheim.de"],["dc.contributor.author","Kaiser, Anna"],["dc.contributor.author","Aggensteiner, Pascal-M."],["dc.contributor.author","Holtmann, Martin"],["dc.contributor.author","Fallgatter, Andreas"],["dc.contributor.author","Romanos, Marcel"],["dc.contributor.author","Abenova, Karina"],["dc.contributor.author","Alm, Barbara"],["dc.contributor.author","Becker, Katja"],["dc.contributor.author","Döpfner, Manfred"],["dc.contributor.author","Ethofer, Thomas"],["dc.contributor.author","Freitag, Christine"],["dc.contributor.author","Geissler, Julia"],["dc.contributor.author","Hebebrand, Johannes"],["dc.contributor.author","Huss, Michael"],["dc.contributor.author","Jans, Thomas"],["dc.contributor.author","Jendreizik, Lea"],["dc.contributor.author","Ketter, Johanna"],["dc.contributor.author","Legenbauer, Tanja"],["dc.contributor.author","Philipsen, Alexandra"],["dc.contributor.author","Poustka, Luise"],["dc.contributor.author","Renner, Tobias"],["dc.contributor.author","Retz, Wolfgang"],["dc.contributor.author","Rösler, Michael"],["dc.contributor.author","Thome, Johannes"],["dc.contributor.author","Uebel-von Sandersleben, Henrik"],["dc.contributor.author","von Wirth, Elena"],["dc.contributor.author","Zinnow, Toivo"],["dc.contributor.author","Hohmann, Sarah"],["dc.contributor.author","Millenet, Sabina"],["dc.contributor.author","Holz, Nathalie"],["dc.contributor.author","Banaschewski, Tobias"],["dc.contributor.author","Brandeis, Daniel"],["dc.contributor.editorcorporation","ESCAlife-Consortium"],["dc.date.accessioned","2021-04-14T08:29:47Z"],["dc.date.available","2021-04-14T08:29:47Z"],["dc.date.issued","2021"],["dc.date.updated","2022-02-09T13:21:21Z"],["dc.description.sponsorship","German Federal Ministry of Education and Research"],["dc.identifier.doi","10.3390/brainsci11020214"],["dc.identifier.eissn","2076-3425"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/82987"],["dc.language.iso","en"],["dc.notes.intern","DOI Import GROB-399"],["dc.publisher","MDPI"],["dc.relation.eissn","2076-3425"],["dc.rights","https://creativecommons.org/licenses/by/4.0/"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0/"],["dc.title","EEG Data Quality: Determinants and Impact in a Multicenter Study of Children, Adolescents, and Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","53"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Psychopathology"],["dc.bibliographiccitation.lastpage","59"],["dc.bibliographiccitation.volume","44"],["dc.contributor.author","Holtmann, Martin"],["dc.contributor.author","Becker, Andreas"],["dc.contributor.author","Banaschewski, Tobias"],["dc.contributor.author","Rothenberger, Aribert"],["dc.contributor.author","Roessner, Veit"],["dc.date.accessioned","2018-11-07T09:01:59Z"],["dc.date.available","2018-11-07T09:01:59Z"],["dc.date.issued","2011"],["dc.description.abstract","Background: In many severely mentally disordered children, the clinical presentation is complicated by comorbid affective and behavioral dysregulation. Recently, a highly heritable behavioral phenotype of simultaneous deviance on the nanxious/depressed, attention problems, and aggressive behavior syndrome scales has been identified on the Child Behavior Checklist Dysregulation Profile (CBCL-DP). The aim of the present pilot study was to determine an equivalent to the CBCL-DP using the Strengths and Difficulties Questionnaire (SDQ). Sampling and Methods: We applied stepwise linear discriminant analyses and receiver operating characteristic (ROC) analysis to data from 543 consecutively referred children and adolescents, aged 5-17 years. The CBCL and the SDQ were completed by parents as part of the diagnostic routine. ICD-10 discharge diagnoses were established in consensus conferences. Results: A combination of five SDQ items (SDQ-Dysregulation Profile, SDQ-DP) yielded the best discrimination of children with and without CBCL-DP and classified 81.0% of the subjects correctly leading to an area under the curve of 0.93. The content of the five SDQ-DP items mirrors well the mixed behavioral phenotype of anxious-depressive, aggressive and attention problems captured by the CBCL-DP. SDQ-DP status was highly correlated with CBCL-DP status and was best defined by a SDQ-DP score >= 5. Conclusions: The psychometric properties of the SDQ-DP have been robustly tested and validated. Based on these results, clinicians may use the SDQ-DP as a useful and economical screening measure to improve the assessment, prevention, and treatment of severe dysregulation in childhood and adolescence. Future investigations should study the longitudinal stability, heritability, and genetic associations of this behavioral phenotype. Copyright (C) 2010 S. Karger AG, Basel"],["dc.identifier.doi","10.1159/000318164"],["dc.identifier.isi","000284157300008"],["dc.identifier.pmid","21072000"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/8050"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/24567"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Karger"],["dc.relation.issn","0254-4962"],["dc.rights","Goescholar"],["dc.rights.uri","https://goescholar.uni-goettingen.de/licenses"],["dc.title","Psychometric Validity of the Strengths and Difficulties Questionnaire-Dysregulation Profile"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","135"],["dc.bibliographiccitation.journal","Frontiers in Human Neuroscience"],["dc.bibliographiccitation.volume","11"],["dc.contributor.author","Strehl, Ute"],["dc.contributor.author","Aggensteiner, Pascal"],["dc.contributor.author","Wachtlin, Daniel"],["dc.contributor.author","Brandeis, Daniel"],["dc.contributor.author","Albrecht, Bjoern"],["dc.contributor.author","Arana, Maria"],["dc.contributor.author","Bach, Christiane"],["dc.contributor.author","Banaschewski, Tobias"],["dc.contributor.author","Bogen, Thorsten"],["dc.contributor.author","Flaig-Roehr, Andrea"],["dc.contributor.author","Freitag, Christine M."],["dc.contributor.author","Fuchsenberger, Yvonne"],["dc.contributor.author","Gest, Stephanie"],["dc.contributor.author","Gevensleben, Holger"],["dc.contributor.author","Herde, Laura"],["dc.contributor.author","Hohmann, Sarah"],["dc.contributor.author","Legenbauer, Tanja"],["dc.contributor.author","Marx, Anna-Maria"],["dc.contributor.author","Millenet, Sabina"],["dc.contributor.author","Pniewski, Benjamin"],["dc.contributor.author","Rothenberger, Aribert"],["dc.contributor.author","Ruckes, Christian"],["dc.contributor.author","Woerz, Sonja"],["dc.contributor.author","Holtmann, Martin"],["dc.date.accessioned","2018-11-07T10:25:59Z"],["dc.date.available","2018-11-07T10:25:59Z"],["dc.date.issued","2017"],["dc.description.abstract","Background: Neurofeedback (NF) in children with attention-deficit/hyperactivity disorder (ADHD) has been investigated in a series of studies over the last years. Previous studies did not unanimously support NF as a treatment in ADHD. Most studies did not control for unspecific treatment effects and did not demonstrate that self-regulation took place. The present study examined the efficacy of NF in comparison to electromyographic (EMG) feedback to control for unspecific effects of the treatment, and assessed self-regulation of slow cortical potentials (SCPs). Methods: A total of 150 children aged 7-9 years diagnosed with ADHD (82% male; 43% medicated) were randomized to 25 sessions of feedback of SCPs (NF) or feedback of coordination of the supraspinatus muscles (EMG). The primary endpoint was the change in parents' ratings of ADHD core symptoms 4 weeks after the end of treatment compared to pre-tests. Results: Children in both groups showed reduced ADHD-core symptoms (NF 0.3, 95% CI 0.42 to 0.18; EMG 0.13, 95% CI 0.26 to 0.01). NF showed a significant superiority over EMG (treatment difference 0.17, 95% CI 0.02-0.3, p = 0.02). This yielded an effect size (ES) of d = 0.57 without and 0.40 with baseline observation carried forward (BOCF). The sensitivity analysis confirmed the primary result. Successful self-regulation of brain activity was observed only in NF. As a secondary result teachers reported no superior improvement from NF compared to EMG, but within-group analysis revealed effects of NF on the global ADHD score, inattention, and impulsivity. In contrast, EMG feedback did not result in changes despite more pronounced self-regulation learning. Conclusions: Based on the primary parent-rated outcome NF proved to be superior to a semi-active EMG feedback treatment. The study supports the feasibility and efficacy of NF in a large sample of children with ADHD, based on both specific and unspecific effects."],["dc.description.sponsorship","German Research Foundation DFGHO [2503/4-1, 2503/4-2]"],["dc.identifier.doi","10.3389/fnhum.2017.00135"],["dc.identifier.isi","000397982900001"],["dc.identifier.pmid","28408873"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/14972"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/42957"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","PUB_WoS_Import"],["dc.publisher","Frontiers Media Sa"],["dc.relation.issn","1662-5161"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","17"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","European Child & Adolescent Psychiatry"],["dc.bibliographiccitation.lastpage","37"],["dc.bibliographiccitation.volume","20"],["dc.contributor.author","Graham, J."],["dc.contributor.author","Banaschewski, Tobias"],["dc.contributor.author","Buitelaar, J. K."],["dc.contributor.author","Coghill, David"],["dc.contributor.author","Danckaerts, Marina"],["dc.contributor.author","Dittmann, Ralf W."],["dc.contributor.author","Doepfner, M."],["dc.contributor.author","Hamilton, R."],["dc.contributor.author","Hollis, Chris"],["dc.contributor.author","Holtmann, Martin"],["dc.contributor.author","Hulpke-Wette, Martin"],["dc.contributor.author","Lecendreux, M."],["dc.contributor.author","Rosenthal, E."],["dc.contributor.author","Rothenberger, A."],["dc.contributor.author","Santosh, Parmala"],["dc.contributor.author","Sergeant, Joseph A."],["dc.contributor.author","Simonoff, E."],["dc.contributor.author","Sonuga-Barke, Edmund J."],["dc.contributor.author","Wong, I. C. K."],["dc.contributor.author","Zuddas, Alessandro"],["dc.contributor.author","Steinhausen, H.-C."],["dc.contributor.author","Taylor, Eric A."],["dc.date.accessioned","2018-11-07T09:01:09Z"],["dc.date.available","2018-11-07T09:01:09Z"],["dc.date.issued","2011"],["dc.description.abstract","The safety of ADHD medications is not fully known. Concerns have arisen about both a lack of contemporary-standard information about medications first licensed several decades ago, and signals of possible harm arising from more recently developed medications. These relate to both relatively minor adverse effects and extremely serious issues such as sudden cardiac death and suicidality. A guidelines group of the European Network for Hyperkinetic Disorders (EUNETHYDIS) has therefore reviewed the literature, recruited renowned clinical sub-specialists and consulted as a group to examine these concerns. Some of the effects examined appeared to be minimal in impact or difficult to distinguish from risk to untreated populations. However, several areas require further study to allow a more precise understanding of these risks."],["dc.description.sponsorship","Lilly; Medice; Novartis; UCB; Shire"],["dc.identifier.doi","10.1007/s00787-010-0140-6"],["dc.identifier.isi","000287397900003"],["dc.identifier.pmid","21042924"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/7625"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/24347"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Springer"],["dc.relation.issn","1435-165X"],["dc.relation.issn","1018-8827"],["dc.title","European guidelines on managing adverse effects of medication for ADHD"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","1038"],["dc.bibliographiccitation.journal","Frontiers in Human Neuroscience"],["dc.bibliographiccitation.volume","8"],["dc.contributor.author","Marx, Anna-Maria"],["dc.contributor.author","Ehlis, Ann-Christine"],["dc.contributor.author","Furdea, Adrian"],["dc.contributor.author","Holtmann, Martin"],["dc.contributor.author","Banaschewski, Tobias"],["dc.contributor.author","Brandeis, Daniel"],["dc.contributor.author","Rothenberger, Aribert"],["dc.contributor.author","Gevensleben, Holger"],["dc.contributor.author","Freitag, Christine M."],["dc.contributor.author","Fuchsenberger, Yvonne"],["dc.contributor.author","Fallgatter, Andreas J."],["dc.contributor.author","Strehl, Ute"],["dc.date.accessioned","2018-11-07T10:02:19Z"],["dc.date.available","2018-11-07T10:02:19Z"],["dc.date.issued","2015"],["dc.description.abstract","In this pilot study near-infrared spectroscopy (NIRS) neurofeedback was investigated as a new method for the treatment of Attention Deficit-/Hyperactivity Disorder (ADHD). Oxygenated hemoglobin in the prefrontal cortex of children with ADHD was measured and fed back. 12 sessions of NIRS-neurofeedback were compared to the intermediate outcome after 12 sessions of EEG-neurofeedback (slow cortical potentials, SCR) and 12 sessions of EMG-feedback (muscular activity of left and right musculus supraspinatus). The task was either to increase or decrease hemodynamic activity in the prefrontal cortex (NIRS), to produce positive or negative shifts of SCP (EEG) or to increase or decrease muscular activity (EMG). In each group nine children with ADHD, aged 7-10 years, took part. Changes in parents' ratings of ADHD symptoms were assessed before and after the 12 sessions and compared within and between groups. For the NIRS-group additional teachers' ratings of ADHD symptoms, parents' and teachers' ratings of associated behavioral symptoms, childrens' self reports on quality of life and a computer based attention task were conducted before, 4 weeks and 6 months after training. As primary outcome, ADHD symptoms decreased significantly 4 weeks and 6 months after the NIRS training, according to parents' ratings. In teachers' ratings of ADHD symptoms there was a significant reduction 4 weeks after the training. The performance in the computer based attention test improved significantly. Within-group comparisons after 12 sessions of NIRS-, EEG- and EMG-training revealed a significant reduction in ADHD symptoms in the NIRS-group and a trend for EEG- and EMG-groups. No significant differences for symptom reduction were found between the groups. Despite the limitations of small groups and the comparison of a completed with two uncompleted interventions, the results of this pilot study are promising. NIRS-neurofeedback could be a time-effective treatment for ADHD and an interesting new option to consider in the treatment of ADHD."],["dc.identifier.doi","10.3389/fnhum.2014.01038"],["dc.identifier.isi","000347519000001"],["dc.identifier.purl","https://resolver.sub.uni-goettingen.de/purl?gs-1/11626"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/38200"],["dc.notes.intern","Merged from goescholar"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Frontiers Media Sa"],["dc.relation.issn","1662-5161"],["dc.rights","CC BY 4.0"],["dc.rights.uri","https://creativecommons.org/licenses/by/4.0"],["dc.title","Near-infrared spectroscopy (NIRS) neurofeedback as a treatment for children with attention deficit hyperactivity disorder (ADHD)-a pilot study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dc.type.version","published_version"],["dspace.entity.type","Publication"]]